Semisynthesis and biological evaluation of a cotylenin A mimic derived from fusicoccin A

[Display omitted] In an effort to overcome the unavailability of cotylenin A (CN A), an anticancer agent and a stabilizer of protein–protein interactions (PPIs) mediated by 14-3-3 proteins, ISIR-050 was designed as a CN A mimic. The synthesis was accomplished via a semisynthetic approach starting fr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2018-02, Vol.28 (4), p.646-650
Hauptverfasser: Inoue, Takatsugu, Higuchi, Yusuke, Yoneyama, Toru, Lin, Bangzhong, Nunomura, Kazuto, Honma, Yoshio, Kato, Nobuo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] In an effort to overcome the unavailability of cotylenin A (CN A), an anticancer agent and a stabilizer of protein–protein interactions (PPIs) mediated by 14-3-3 proteins, ISIR-050 was designed as a CN A mimic. The synthesis was accomplished via a semisynthetic approach starting from fusicoccin A. ISIR-050 showed interferon-α (IFNα)-dependent growth inhibitory activity and a PPI stabilization effect similar to those of CN A. The biochemical analysis suggested that ISIR-050 and CN A induce the same pharmacological response to IFNα-treated cancer cells and that 14-3-3 proteins play a role in the mode of action.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2018.01.030